Omkar Pharmachem Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jan '25 Jan 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	2015 - 2019
Market Capitalization	303	227	252	206	209	160	Upgrade
Market Cap Growth	37.74%	-10.08%	22.55%	-1.44%	30.19%	24.22%	Upgrade
Enterprise Value	304	231	259	214	217	167	Upgrade
Last Close Price	30.00	22.48	25.00	20.40	20.70	15.90	Upgrade
PE Ratio	146.53	119.88	127.45	112.35	94.28	-	Upgrade
PS Ratio	56.02	41.98	46.69	38.10	77.31	356.29	Upgrade
PB Ratio	3.23	2.46	2.79	2.33	2.41	1.90	Upgrade
P/TBV Ratio	3.23	2.46	2.79	2.33	2.41	1.90	Upgrade
P/FCF Ratio	-	79.18	91.37	104.96	931.84	-	Upgrade
P/OCF Ratio	-	76.69	91.37	101.44	931.84	-	Upgrade
EV/Sales Ratio	56.25	42.74	47.92	39.69	80.52	372.00	Upgrade
EV/EBITDA Ratio	100.58	81.52	83.24	79.76	997.23	-	Upgrade
EV/EBIT Ratio	102.69	82.90	83.97	80.33	1045.17	-	Upgrade
EV/FCF Ratio	-	80.61	93.80	109.34	970.51	-	Upgrade
Debt / Equity Ratio	0.03	0.03	0.07	0.11	0.10	0.10	Upgrade
Debt / EBITDA Ratio	1.00	1.07	2.00	3.46	41.39	-	Upgrade
Debt / FCF Ratio	-	1.06	2.25	4.74	40.29	-	Upgrade
Asset Turnover	-	0.06	0.06	0.06	0.03	0.01	Upgrade
Quick Ratio	-	0.33	0.26	0.22	0.05	0.06	Upgrade
Current Ratio	-	0.51	0.38	0.30	0.07	0.06	Upgrade
Return on Equity (ROE)	-	2.07%	2.21%	2.09%	2.59%	-3.03%	Upgrade
Return on Assets (ROA)	-	1.80%	1.97%	1.71%	0.14%	-1.38%	Upgrade
Return on Capital (ROIC)	1.91%	1.81%	1.98%	1.72%	0.14%	-1.39%	Upgrade
Return on Capital Employed (ROCE)	-	3.00%	3.40%	3.00%	0.20%	-	Upgrade
Earnings Yield	0.68%	0.83%	0.78%	0.89%	1.06%	-1.62%	Upgrade
FCF Yield	-	1.26%	1.09%	0.95%	0.11%	-1.34%	Upgrade
Buyback Yield / Dilution	-0.01%	-	-	-	-	-0.00%	Upgrade

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.